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Abstract
Background: The Esmeraldas focus of onchocerciasis in Ecuador expanded geographically during the 1980s and
was associated with severe ocular and skin disease. Mass drug administration (MDA) with ivermectin started in
1991, initially once but later twice a year, in the principle endemic focus followed by all satellite foci. Treatment was
stopped in 2009 when entomological assessments determined that transmission of Onchocerca volvulus had been
interrupted.
Methods: Three years after the cessation of ivermectin treatment in 2012, as defined by the WHO guidelines for
onchocerciasis elimination, blackfly collections were done in four sentinel sites in former hyperendemic areas. The
presence of infective larvae in local vectors, Simulium exiguum and Simulum quadrivittatum, was assessed by
detection of O. volvulus DNA by PCR. Additional flies captured in four extra-sentinel sites located in former hyper-
and mesoendemic dispersed isolated areas were also assessed.
Results: The results from 68,310 captured blackflies, 40,114 from four sentinel villages in the previously
hyperendemic areas (Corriente Grande, El Tigre, San Miguel on Río Cayapas and Naranjal on Río Canandé) and
28,197 from extra-sentinel locations, were all negative for the presence of O. volvulus. These extra-sentinel sites
(Hualpí on Río Hoja Blanca, Capulí on Río Onzole, La Ceiba on Río Tululví and Medianía on Río Verde) were
included to provide additional evidence of the impact of MDA on the transmission of O. volvulus in isolated
endemic areas.
Conclusions: Our data indicate that transmission of O. volvulus has been stopped in all endemic areas in Ecuador,
including all satellite foci outside the main focus. These findings indicate that a strategy of ivermectin distribution
twice a year to over 85% of the treatment-eligible population was effective in eliminating the infection from
Ecuador in a focus with a highly competent primary vector, S. exiguum, and where the infection rates were equal to
or greater than observed in many onchocerciasis foci in Africa.
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Background
Onchocerciasis (“river blindness”), caused by the filarial
parasite O. volvulus, has historically been a major cause
of blindness and hindered economic development
worldwide [1, 2]. Treatment was revolutionized by the
discovery that ivermectin (Mectizan®) was safe and ef-
fective for mass distribution, and by the decision by
Merck & Co. to donate the drug for the treatment and
control of onchocerciasis [1, 2]. Observations on the
effects of ivermectin on the transmission of O. volvulus
in Guatemala [3, 4] raised the possibility that mass dis-
tribution of ivermectin at a community-wide level, either
annually or semi-annually, might prove sufficient to
eliminate the disease through breaking transmission of
the parasite. The first programme to implement an elim-
ination rather than a control strategy for onchocerciasis
based on ivermectin was the Onchocerciasis Elimination
Programme of the Americas (OEPA). OEPA’s strategy
was to provide semi-annual treatments with ivermectin
at a coverage rate ≥ 85% of all eligible individuals* Correspondence: agguevara@uce.edu.ec
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residing in the 13 foci of onchocerciasis in the six en-
demic countries in Latin America.
By ensuring high coverage rates in the eligible popula-
tion over a period of several years, it was believed that
transmission of the parasite could be suppressed for a
long enough period such that the parasite population
would eventually be pushed below the transmission
breakpoint, and the parasite population would become
locally extinct. The World Health Organization (WHO)
developed a series of metrics, relying upon entomo-
logical and epidemiological indicators to determine
when transmission had been suppressed, originally pub-
lished in 2001 [5] and revised in 2016 [6]. These guide-
lines envisioned that mass drug administration could be
stopped once transmission was determined to have been
interrupted, followed by a three to five year period of
post-treatment surveillance (PTS) at the end of which
entomological surveys would be done to detect recru-
descence of transmission. If no evidence for ongoing
transmission was observed at this time, it could be con-
cluded that transmission had been eliminated.
Ecuador is one of six endemic countries for onchocer-
ciasis in Latin America where the infection was confined
to a geographically delimited area within the Province of
Esmeraldas, located in the northwest region of the coun-
try, a rainforest area characterized by complex river sys-
tems (Fig. 1). An updated population census in 2008
showed 25,506 people to be living in the endemic area
in 119 communities. The vectors in the focus include S.
exiguum and S. quadrivittatum, with the former being
the primary vector. Simulium exiguum has been
shown to be a highly efficient vector for O. volvulus
[7–11] while S. quadrivittatum is much less efficient
due to the presence of a cibarial armature that dam-
ages the parasites. Epidemiological studies during the
1980s documented a dramatic increase in the inten-
sity of transmission [12–18]. In addition, surveys dur-
ing the 1980s and 1990s documented the
geographical extension of onchocerciasis from the
principal focus in the Santiago River Basin to satellite
foci other river systems within and outside Esmeral-
das Province caused by migrations of O. volvulus-in-
fected individuals.
Ivermectin mass drug administration, given either an-
nually or semi-annually, started in 1991 in affected com-
munities and entomological and epidemiological surveys
in 2008 indicated that transmission throughout the
former endemic area had been interrupted [19]. The Na-
tional Elimination Programme for Onchocerciasis
stopped MDA in the sub-focus on the Rio Santiago in
2008 and in all other foci in 2009, moving into a three-
year post-treatment surveillance (PTS) phase to confirm
elimination of the infection [5, 19]
This present study presents the results of the PTS
entomological surveys done in 2012 at the end of a 3-
year PTS period.
Fig. 1 Location of sentinel and extra-sentinel communities include in the post-treatment survey, 3 years after the cessation of MDA
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Methods
Study area
The principal focus was in Esmeraldas Province in the
Santiago River Basin, formed by three major river sys-
tems of Río Cayapas, Río Santiago and Río Onzole (Fig.
1) [12, 13]. Satellite endemic foci were located on separ-
ate river systems [17]: five were found on the rivers, Río
Canandé, Río Verde, Río Viche, Río Sucio and Río
Tululví; and a small focus was found in the neighboring
Province of Santo Domingo de los Tsáchilas. The area
has dense tropical vegetation with a high annual rainfall
(up to 8000 mm annually). Simulium exiguum and S.
quadrivittatum vectors breed on rocks and vegetation in
fast-flowing rivers with a peak biting period between
April and June.
The population was comprised largely of two ethnic
groups, Chachi Amerindians and Afro-Ecuadorians, liv-
ing in small riverine settlements. The National Elimin-
ation Programme for Onchocerciasis maintained a
regularly updated census on the total population using
local community health workers who were responsible
also for ivermectin treatments. Ivermectin MDA was
distributed annually to semi-annually following standard
guidelines [2] between 1990 and 2009 with the last dose
being given in December 2009. Between 23 and 30
rounds of annual or semi-annual ivermectin MDA was
given with high rates of coverage in affected communi-
ties [19]. Entomological and serological evaluations,
done in 2008 at 4 sentinel sites, showed neither evidence
of infection in 48,918 blackflies nor evidence of the pres-
ence of O. volvulus-specific antibodies in a total of 609
children aged up to 15 years, indicating the interruption
of transmission, and leading to the suspension of treat-
ment in 2009 [19]. No ocular microfilariae had been ob-
served in any individual in surveys done after 2000 [19].
All four sentinel sites evaluated in 2009 were evaluated
in the present study. Sentinel communities on the Rio
Santiago were also hyperendemic prior to ivermectin:
MDA was stopped in these communities in 2007, based
on an absence of infected flies and seropositive children,
and negative parasitological and clinical surveys in 2000
and 2004.
Sample collection
The four sentinel sites chosen for the final PTS evalu-
ation were formerly hyperendemic villages: Corriente
Grande, El Tigre and San Miguel on Río Cayapas, and
Naranjal on Río Canandé. These sites had been used for
previous surveys [13–16]. Four extra-sentinel sites
chosen for PTS evaluation were former hyper- and
mesoendemic villages: Hualpí on Río Hoja Blanca,
Capulí on Rio Onzole, Medianía on Río Verde and La
Ceiba on Río Tululví (Fig. 1). The four extra-sentinel
communities were included in the PTS evaluation in
support of the data collected in hyperendemic sentinel
communities and to ensure that the findings in the per-
ipheral geographical endemic areas were representative
of the transmission status of the whole endemic zone.
The eight communities selected for PTS, received be-
tween 25 and 35 annual or semi-annual treatments with
ivermectin from 1990 to 2009 when MDA was stopped
[19] (Fig. 2). Flies were collected using standard
methods [15] from 08:00–17:00 h each day for 8 days
per month in April-June 2012. Collection sites in senti-
nel communities were those where human-fly contact
was greatest and were generally shady areas close to
riverbanks within the communities. Flies were collected
for 50 min each hour, allowing a 10 min break, then
sorted according to species (S. exiguum and S. quadri-
vittatum), divided into pools containing a maximum of
50 individuals of each species per pool, placed in iso-
propanol and stored at room temperature until ana-
lyzed by PCR.
Entomological (PCR) testing
Heads and bodies from the collected flies were separated
by freezing, agitation and separation through a 25 mesh
sieve [20]. DNA was extracted following proteinase K di-
gestion, organic extraction and adsorption to a silica
matrix [21]. Pools were processed in groups of 12, with
each group consisting of 11 fly pools and one sham ex-
traction (i.e. containing PCR reagents in the absence of
flies) serving as an internal negative control. The result-
ing DNA preparations were used as templates in a PCR
assay targeting an O. volvulus-specific repeated sequence
(O-150 PCR). The PCR products were detected by PCR-
ELISA [20, 21]. Pools were regarded as putatively posi-
tive for O. volvulus DNA when ELISA values were equal
to or greater than the mean plus three standard devia-
tions of the values obtained from 10 negative control
wells run on each plate. Putatively positive DNA samples
were then re-tested in an independent PCR reaction.
Samples that were positive in both assays were classified
as “confirmed positives”. Pools of bodies were initially
screened, as bodies contain early stage larvae (microfilar-
ial and L2 stages) are the most sensitive indicator of
parasite-vector contact. The prevalence of flies contain-
ing immature stages is 2-fold higher than the prevalence
of flies containing infective third-stage larvae (L3) in S.
exiguum and 20-fold higher in S. quadrivittatum [22].
DNA from head pools were screened if evidence for
parasite-vector contact was observed in the screens of
the body pools to obtain an estimate of the prevalence
of flies containing L3.
Statistical methods
The upper limit of the 95% confidence interval for infec-
tion rate of flies carrying O. volvulus parasites was
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calculated using a Bayesian algorithm from Poolscreen v.
2.0. Upper limits for the 95% confidence interval for the
seasonal transmission potential were calculated as the
products of the upper limits of the 95% confidence inter-
vals for the seasonal biting rate, the prevalence of in-
fected flies and the mean number of infective stage
larvae per fly, as previously described [22]. In undertak-
ing these calculations, the mean number of L3s per in-
fective fly was taken as 1, as reported to be the case in
areas where there are effective control measures.
Results
Blackfly populations
A total of 68,311 flies were collected from the eight
communities in April and June (i.e. during the peak
transmission season in the Esmeraldas focus) in 2012.
Simulium. exiguum made up approximately 75% of flies
and was the dominant species collected in all communi-
ties except for La Ceiba (Table 1).
PCR detection of infected flies
Flies were grouped by community and species into pools
and screened for the presence of O. volvulus DNA by
PCR. None of the pools were found to be positive giving
a point estimate for the prevalence of infection in the fly
population (and the associated point estimate of the sea-
sonal transmission potential) of zero (Table 2). The
upper limit of the 95% confidence interval for the rate of
O. volvulus infected flies ranged from 0.1 to 1.2 per 2000
flies sampled in the different communities (depending
upon the number of flies collected from each commu-
nity). However, the upper limit of the infection rate in
the fly population in the focus as a whole was 0.1 per
2000 flies sampled (Table 2). Similarly, the upper limit of
the 95% confidence interval for the seasonal transmis-
sion potential for each community ranged from 6.4 to
17.4, and was 1.0 for the focus as a whole (Table 2).
When the data were analyzed by species, the upper limit
of the 95% confidence interval for the infection rates in
S. exiguum and S. quadrivittatum was 0.1/2000 and 0.2/
2000 flies, respectively (Table 3). The upper limit of the
95% confidence interval for the seasonal transmission
potential for both species was less than one L3 per year
(Table 2).
Discussion
Following the description of the first case of onchocer-
ciasis in Ecuador in 1980 [23], the principal endemic
focus in Province of Esmeraldas has been extensively de-
scribed. Up until 1991, disease control relied on a sys-
tematic programme of surgical nodulectomies that had
limited success in reducing infection indices in the hy-
perendemic foci. A mass drug administration
programme with annual or semi-annual treatments with
ivermectin was initiated in 1991 in which coverage of
over 85% of the eligible population was consistently
Fig. 2 Ivermectin treatments received by the communities involved in the study: the number of annual-only treatments (solid green bars) and
the number of semi-annual treatments administered (blue bars). Corriente Grande, El Tigre, San Miguel and Naranjal are sentinel village sites in
the main focus; Hualpí, Capulí, La Ceiba and Medianía are extra-sentinel villages
Table 1 Post-treatment surveillance blackfly collections at
sentinel and extra-sentinel communities in 2012: total number
of flies examined
Community Type S. exiguum S. quadrivittatum
Corriente Grande Sentinel 8272 1604
El Tigre Sentinel 4188 3565
San Miguel Sentinel 7024 426
Naranjal Sentinel 14,639 396
Capulí Extra-sentinel 3182 5
Hualpí Extra-sentinel 6972 3672
Medianía Extra-sentinel 7212 1
La Ceiba Extra-sentinel 3 7150
Total 51,492 16,819
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achieved for much of the 16-year period of the
programme. Findings of entomological and serological
surveys indicated that transmission had been interrupted
and ivermectin MDA was stopped in 2009 [19]. The
present study provides the findings of post-treatment
surveillance (PTS) and shows, after at least three years
of stopping treatment, no active transmission of O. vol-
vulus infection in any of the sampled blackfly
populations.
Post-treatment surveillance (PTS) was done in 2012 in
accordance with the 2001 WHO guidelines for the verifi-
cation of onchocerciasis elimination [5]. This assessment
included fly collections in sentinel sites in the formerly
hyperendemic region in the Santiago River Basin: none
of the 40,114 flies collected were found to be positive for
O. volvulus by PCR. Extra-sentinel sites were surveyed
to ensure that transmission had been successfully con-
tained: none of the 28,197 flies collected from these sites
were positive for O. volvulus DNA. Extra-sentinel sites
were included in PTS because previous studies had
shown that infected individuals who had migrated from
the Santiago River Basin focus to these communities had
led to the establishment of new satellite foci in areas
where a suitable vector was present.
The Ecuadorian National Elimination Programme for
Onchocerciasis has concluded that after over 15 years of
annual and semi-annual mass drug administration with
ivermectin in the endemic foci in Ecuador, O. volvulus
transmission had been eliminated in Ecuador in
accordance with past [5] and current [6] WHO criteria
for the elimination of this infection. Based on the well-
documented history of the MDA programme in Ecuador
and the results of entomological and clinical surveys that
showed no evidence of transmission up to the halting of
treatment and during the three years of PTS, the
Ecuador programme requested external verification of
the interruption of transmission and approval of the sta-
tus of elimination of O. volvulus transmission. The
WHO certified the elimination of onchocerciasis from
Ecuador in September 2014. This success was achieved
in an endemic focus with special challenges for disease
control and elimination. First, the dominant vector, S.
exiguum, was a particularly voracious and effective
transmitter of the parasite [8–11, 21, 22], and secondly,
the onchocercal skin and eye disease in this focus was
arguably the most severe form in the Americas [13, 14,
18, 24].
Among the important factors contributing to this
achievement were: (i) the effective leadership and oper-
ational expertise of the programme combined with con-
stant and close interactions with affected communities;
and (ii) a semi-annual treatment schedule combined
with high coverage rates. Key actors in the success of
this treatment-based strategy were community health
workers (CHWs), supported closely by the National
Elimination Programme for Onchocerciasis team and in-
tegrated within multi-disciplinary health teams providing
a broad range of health services and educational













Corriente Grande 9876 236 0 0 (0–0.39) 56,867 (53,162–60,825) 0 (0–11.1)
El Tigre 7753 216 0 0 (0–0.49) 40,797 (38,821–42,872) 0 (0–10.0)
San Miguel 7450 200 0 0 (0–0.51) 27,833 (25,218–30,708) 0 (0–7.1)
Naranjal 15,035 328 0 0 (0–0.26) 133,890 (117,616–152,396) 0 (0–17.4)
Capulíc 3187 81 0 0 (0–1.20) 10,739 (9929–11,609) 0 (0–6.4)
Hualpíc 10,644 226 0 0 (0–0.40) 65,127 (60,981–69,550) 0 (0–11.7)
Medianíac 7213 154 0 0 (0–0.50) 24,615 (21,388–28,305) 0 (0–6.5)
La Ceibac 7153 151 0 0 (0–0.50) 38,348 (36369–40,432) 0 (0–10.2)
Total 68,311 1592 0 0 (0–0.10) 34,117 (32,796–35,490) 0 (0–1.0)
aNumber infected flies per 2000 flies sampled
bShown are point estimates and 95% confidence intervals (CI)
cExtra-sentinel sites













S. exiguum 51,492 1225 0 0 (0–0.1) 16,275 (14,931–17,731) 0 (0–0.6)
S. quadrivittatum 16,819 367 0 0 (0–0.2) 4655 (4217–5128) 0 (0–0.5)
aNumber of infected flies per 2000 flies sampled
bShown are point estimates and 95% confidence intervals (CI)
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activities to endemic communities. Such activities en-
sured high rates of treatment coverage long after oncho-
cerciasis was perceived as a health problem in endemic
communities. Treatments were directly observed and
censuses were updated semi-annually by CHWs with in-
dividualized information on numbers of treatments re-
ceived. CHWs were supported in their activities directly
by local Ministry of Public Health and NGO health
personnel. Despite the remoteness of many of the resi-
dents of the area due to the extensive river systems, the
national team placed considerable emphasis on main-
taining up-to-date knowledge of the changing situation
with regards to migration, coverage rates and the
provision of medical care. These factors undoubtedly
contributed to the success of the programme.
An important consideration for any disease elimin-
ation programme is the possibility of spread of the infec-
tion to new areas through migrations of uninfected
individuals into areas where transmission is still active
or through migrations of infected individuals to un-
affected areas where suitable vectors are present. In
addition, previous residents of an endemic area who
have not received treatment but who carry the infection,
could return to an area where transmission has been
suppressed and reintroduce infection, thus re-
establishing transmission. Key to the establishment of
new focus is the presence of a competent vector(s) cap-
able of initiating and maintaining transmission. The vec-
torial capacities of Simulium sp. have been studied in
several infection foci in Ecuador including studies of cy-
totaxonomy [25–29]. Satellite foci were identified
through a combination of methods that included an-
thropological evaluations of migration patterns within
the Santiago River Basin focus and community censuses
to identify origins of new in-migrants and destinations
of out-migrants. Based on these findings, the programme
identified potential regions that could be potential sites
of new foci and did surveys in all these sites between
1985 and 1995 that included entomological surveys for
the presence of potential vector species of Simulium
blackflies and community surveys for the presence of in-
fection. These studies identified satellite foci within and
adjacent to Esmeraldas Province to which infected Cha-
chilla Amerindians had migrated and demonstrated au-
tochthonous transmission in some [17, 30, 31]. Through
these studies it was established that as few as 4–6 O. vol-
vulus-infected migrants could set up a new focus of in-
fection, an event most likely determined by factors such
as number of infected migrants, their respective microfi-
larial loads, and the competence of the local vector for
parasite transmission [30].
These studies showed, however, that the areas outside
the established foci capable of supporting parasite trans-
mission were limited. Those identified as new foci were
monitored closely by the national programme both be-
fore and after MDA [16, 17]. Mathematical models of
onchocerciasis transmission have suggested that the
force of infection is strongly influenced both by the
competence of the local vector and the amount of
human-vector contact, measured by the biting rate [21,
32]. The higher the biting rate and the more competent
the vector, the greater the force of infection and the
more difficult to eradicate the infection from a focus. In
the Esmeraldas focus, the primary vector S. exiguum, is
an efficient vector, equaling the competence of forest S.
damnosum (s.l.) cytotypes in Africa, in terms of the per-
centage of flies developing infective-stage larvae and the
numbers of larvae per infected fly [9]. In addition, S. exi-
guum has been estimated to have high biting rates esti-
mated at 385 and 733 third-stage larvae/person in the
communities of San Miguel and El Tigre, respectively
[33]. Together, these factors suggested that onchocercia-
sis would, at least theoretically, prove to be difficult to
eliminate from Ecuador.
Our data provide strong evidence that transmission
has not resumed in Ecuador in the three years between
the last ivermectin treatment and the time of this PTS
entomological survey. Current 2016 WHO guidelines for
the certification of the elimination of transmission of O.
volvulus [6] state that there should be < 1 infective fly
per 2000 (0.05%) flies tested assuming that 50% of flies
are parous. To reach this operational threshold, a mini-
mum sample size required to have enough power to de-
tect a statistically significant prevalence of infective flies
lower than 0.05% (i.e. not included in the 95% Cl), given
that no infective fly may be found, is at least 6000 flies
per community [6]. In this survey, no evidence of infec-
tion was seen in an analysis of over 60,000 flies collected
from eight communities in the Esmeraldas focus. This
included over 50,000 S. exiguum, the primary vector for
O. volvulus in the focus, and over 10,000 S. quadrivitta-
tum, the secondary vector. Taken together, the upper
bound of the 95% confidence interval for the prevalence
of flies carrying O. volvulus was ten-fold less that the 1/
2000 cut-off established by OEPA. These data strongly
support the assertion that transmission of O. volvulus
has been eliminated from Ecuador.
Before stopping ivermectin MDA, the Programme
established a surveillance system in which onchocercia-
sis became a mandatory notifiable disease within the na-
tional surveillance system of the Ecuadorian Ministry of
Public Health. At the start of PTS, which began in the
Rio Santiago focus in 2008 and in the remaining en-
demic areas in 2009, communities were notified of visits
by programme staff through the network of CHWs. Each
formerly endemic community was visited by programme
staff performing three basic activities: providing (i) infor-
mation and education about why ivermectin treatment
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was being stopped through community assemblies; (ii)
clinical palpation for potential onchocercal nodules; and
(iii) medical and dental care provided by a multidiscip-
linary team from the Ministry of Health. These visits
were done annually over the three-year PTS period.
CHWs attended workshops on PTS and were respon-
sible for updating community censuses and detection for
suspicious nodules or clinical disease indicating recru-
descence of onchocerciasis. Suspicious clinical findings
were discussed at monthly meetings of CHWs at a cen-
tral location with programme staff. Similarly, annual
treatments with albendazole were provided through
CHWs in endemic communities for the treatment of in-
testinal parasites. Suspect nodules (all confirmed not to
be of onchocercal origin) were removed at annual surgi-
cal field clinics. Furthermore, special bilingual educa-
tional materials and a newsletter (‘Hora Onco’) were
distributed to each household in the communities to no-
tify the communities about planned visits, community
assemblies, and educational workshops. The combin-
ation of these continuous activities ensured that the
communities were well informed about the cessation of
ivermectin MDA and the need for continuing surveil-
lance for recrudescence of infection.
Conclusions
The finding that the interruption in vector transmission
has been maintained over a period of three years since
the cessation of treatment in 2009 strongly supports the
conclusion that Ecuador has indeed eliminated oncho-
cerciasis. Thus, these results strongly suggest that the
elimination of microfilarial infection by ivermectin
MDA, perhaps optimally when administered every six
months, coupled with any residual effects these recur-
rent treatments might have on adult worm survival, can
be achieved even under circumstances of unusually high
annual biting rates by a competent vector.
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